Rhubarb Enema Improved Colon Mucosal Barrier Injury in 5/6 Nephrectomy Rats May Associate With Gut Microbiota Modification

Overview

Journal Front Pharmacol

Date 2020 Aug 28

PMID 32848732

Citations 29

Authors

Chunlan Ji

Yusheng Deng

Aicheng Yang

Zhaoyu Lu

Yang Chen

Xusheng Liu

Lijuan Han

Chuan Zou

Affiliations

Soon will be listed here.

Abstract

Chronic kidney disease (CKD) is often accompanied with colon mucosal barrier damage and gut microbiota disturbance, which strongly associate with up-regulated inflammation and kidney tubulointerstitial fibrosis. However, few interventions could protect the damaged barrier effectively. L or rhubarb is a common herbal medicine which is widely used to protect the colon mucosal barrier. In previous studies, we found that rhubarb intervention may reduce renal inflammation and tubulointerstitial fibrosis, gut microbiota modification. However, whether intestinal barrier function could be improved by rhubarb intervention and the relationship with intestinal flora are still unknown. Therefore, we investigated the effects of rhubarb enema on intestinal barrier, and further analyzed the relationship with gut microbiota in 5/6 nephrectomy rats. Results indicated that rhubarb enema improved the intestinal barrier, regulated gut microbiota dysbiosis, suppressed systemic inflammation, and alleviated renal fibrosis. More specifically, rhubarb enema treatment inhibited the overgrowth of conditional pathogenic gut bacteria, including , , and in CKD. The modification of gut microbiota with rhubarb intervention displayed significant correlation to intestinal barrier markers, TLR4-MyD88-NF-κB inflammatory response, and systemic inflammation. These results revealed that rhubarb enema could restore intestinal barrier by modifying several functional enteric bacteria, which may further explain the renal protection mechanism of the rhubarb enema.

Citing Articles

Shenshuaikang enema restores the intestinal barrier and microbiota-gut-kidney axis balance to alleviate chronic kidney disease via NF-κB pathway.

Ye Y, Huang X, Li X, Gao F, Zhong W, Tang A Front Pharmacol. 2025; 15:1453668.

PMID: 39906395 PMC: 11790348. DOI: 10.3389/fphar.2024.1453668.

Curcumin modulated gut microbiota and alleviated renal fibrosis in 5/6 nephrectomy-induced chronic kidney disease rats.

Li C, Chen X, Yao J, Zha W, Li M, Shen J PLoS One. 2025; 20(1):e0314029.

PMID: 39787157 PMC: 11717218. DOI: 10.1371/journal.pone.0314029.

Multiple benefits of herbs: Polygonaceae species in veterinary pharmacology and livestock nutrition.

Turk Z, Leiber F, Schlittenlacher T, Hamburger M, Walkenhorst M Vet Anim Sci. 2024; 27:100416.

PMID: 39720831 PMC: 11667078. DOI: 10.1016/j.vas.2024.100416.

Potential of natural products and gut microbiome in tumor immunotherapy.

Cao L, Wang X, Ma X, Xu M, Li J Chin Med. 2024; 19(1):161.

PMID: 39567970 PMC: 11580227. DOI: 10.1186/s13020-024-01032-7.

Comprehensive spatial distribution profiling of bioactive emodin in mouse organs using mass spectrometry imaging.

Han S, Fu X, Ha W, Shi Y Anal Sci. 2024; 40(11):2063-2073.

PMID: 39136850 DOI: 10.1007/s44211-024-00644-1.

References

Metidji A, Omenetti S, Crotta S, Li Y, Nye E, Ross E . The Environmental Sensor AHR Protects from Inflammatory Damage by Maintaining Intestinal Stem Cell Homeostasis and Barrier Integrity. Immunity. 2018; 49(2):353-362.e5. PMC: 6104739. DOI: 10.1016/j.immuni.2018.07.010. View

Feng Y, Wang Y, Wang P, Huang Y, Wang F . Short-Chain Fatty Acids Manifest Stimulative and Protective Effects on Intestinal Barrier Function Through the Inhibition of NLRP3 Inflammasome and Autophagy. Cell Physiol Biochem. 2018; 49(1):190-205. DOI: 10.1159/000492853. View

Ramezani A, Massy Z, Meijers B, Evenepoel P, Vanholder R, Raj D . Role of the Gut Microbiome in Uremia: A Potential Therapeutic Target. Am J Kidney Dis. 2015; 67(3):483-98. PMC: 5408507. DOI: 10.1053/j.ajkd.2015.09.027. View

Meijers B, Farre R, Dejongh S, Vicario M, Evenepoel P . Intestinal Barrier Function in Chronic Kidney Disease. Toxins (Basel). 2018; 10(7). PMC: 6071212. DOI: 10.3390/toxins10070298. View

Stubbs J, House J, Ocque A, Zhang S, Johnson C, Kimber C . Serum Trimethylamine-N-Oxide is Elevated in CKD and Correlates with Coronary Atherosclerosis Burden. J Am Soc Nephrol. 2015; 27(1):305-13. PMC: 4696571. DOI: 10.1681/ASN.2014111063. View

Williams J, Duckworth C, Watson A, Frey M, Miguel J, Burkitt M . A mouse model of pathological small intestinal epithelial cell apoptosis and shedding induced by systemic administration of lipopolysaccharide. Dis Model Mech. 2013; 6(6):1388-99. PMC: 3820262. DOI: 10.1242/dmm.013284. View

Nakabayashi I, Nakamura M, Kawakami K, Ohta T, Kato I, Uchida K . Effects of synbiotic treatment on serum level of p-cresol in haemodialysis patients: a preliminary study. Nephrol Dial Transplant. 2010; 26(3):1094-8. DOI: 10.1093/ndt/gfq624. View

Wei X, Yang Z, Rey F, Ridaura V, Davidson N, Gordon J . Fatty acid synthase modulates intestinal barrier function through palmitoylation of mucin 2. Cell Host Microbe. 2012; 11(2):140-52. PMC: 3285413. DOI: 10.1016/j.chom.2011.12.006. View

Gryp T, Vanholder R, Vaneechoutte M, Glorieux G . p-Cresyl Sulfate. Toxins (Basel). 2017; 9(2). PMC: 5331431. DOI: 10.3390/toxins9020052. View

10.

Lu Z, Zeng Y, Lu F, Liu X, Zou C . Rhubarb Enema Attenuates Renal Tubulointerstitial Fibrosis in 5/6 Nephrectomized Rats by Alleviating Indoxyl Sulfate Overload. PLoS One. 2015; 10(12):e0144726. PMC: 4684395. DOI: 10.1371/journal.pone.0144726. View

11.

Chen L, Chen D, Liu J, Zhang J, Vaziri N, Zhuang S . Unilateral ureteral obstruction causes gut microbial dysbiosis and metabolome disorders contributing to tubulointerstitial fibrosis. Exp Mol Med. 2019; 51(3):1-18. PMC: 6437207. DOI: 10.1038/s12276-019-0234-2. View

12.

Bruck K, Stel V, Gambaro G, Hallan S, Volzke H, Arnlov J . CKD Prevalence Varies across the European General Population. J Am Soc Nephrol. 2015; 27(7):2135-47. PMC: 4926978. DOI: 10.1681/ASN.2015050542. View

13.

Kelly C, Zheng L, Campbell E, Saeedi B, Scholz C, Bayless A . Crosstalk between Microbiota-Derived Short-Chain Fatty Acids and Intestinal Epithelial HIF Augments Tissue Barrier Function. Cell Host Microbe. 2015; 17(5):662-71. PMC: 4433427. DOI: 10.1016/j.chom.2015.03.005. View

14.

McClellan W, Flanders W . Risk factors for progressive chronic kidney disease. J Am Soc Nephrol. 2003; 14(7 Suppl 2):S65-70. DOI: 10.1097/01.asn.0000070147.10399.9e. View

15.

Faith J, Guruge J, Charbonneau M, Subramanian S, Seedorf H, Goodman A . The long-term stability of the human gut microbiota. Science. 2013; 341(6141):1237439. PMC: 3791589. DOI: 10.1126/science.1237439. View

16.

Feng Y, Cao G, Chen D, Vaziri N, Chen L, Zhang J . Microbiome-metabolomics reveals gut microbiota associated with glycine-conjugated metabolites and polyamine metabolism in chronic kidney disease. Cell Mol Life Sci. 2019; 76(24):4961-4978. PMC: 11105293. DOI: 10.1007/s00018-019-03155-9. View

17.

Chang C, Lin C, Lu C, Martel J, Ko Y, Ojcius D . Corrigendum: Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota. Nat Commun. 2017; 8:16130. PMC: 5508223. DOI: 10.1038/ncomms16130. View

18.

Wang H, Zhang W, Zuo L, Dong J, Zhu W, Li Y . Intestinal dysbacteriosis contributes to decreased intestinal mucosal barrier function and increased bacterial translocation. Lett Appl Microbiol. 2013; 58(4):384-92. DOI: 10.1111/lam.12201. View

19.

Xiong Y, Chen L, Fan L, Wang L, Zhou Y, Qin D . Free Total Rhubarb Anthraquinones Protect Intestinal Injury via Regulation of the Intestinal Immune Response in a Rat Model of Severe Acute Pancreatitis. Front Pharmacol. 2018; 9:75. PMC: 5816759. DOI: 10.3389/fphar.2018.00075. View

20.

Cao C, Hui L, Li C, Yang Y, Zhang J, Liu T . In vitro study of the nephrotoxicity of total Dahuang (Radix Et Rhizoma Rhei Palmati) anthraquinones and emodin in monolayer human proximal tubular epithelial cells cultured in a transwell chamber. J Tradit Chin Med. 2020; 39(5):609-623. View